Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Biogen’s new Alzheimer’s drug to raise Medicare costs (NASDAQ:BIIB) Markets May 14, 2023 zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B – $5B…
